Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugen Schülter

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|February 9, 2010
The evolution of protease mutation 76V is associated with protease mutation 46I and gag mutation 431VElena Knops, Ina Kemper, Eugen Schülter, et al.
Medical Microbiology and Immunology|January 21, 2012
Endogenous or exogenous spreading of HIV-1 in Nordrhein-Westfalen, Germany, investigated by phylodynamic analysis of the RESINA Study cohortGlenn Lawyer, Eugen Schülter, Rolf Kaiser, et al.
Journal of the International AIDS Society|November 15, 2014
Time on drug analysis based on real life dataEugen Schülter, Rolf Kaiser, Maurizio Zazzi, et al.
Medical Microbiology and Immunology|December 28, 2011
Mutational patterns in the frameshift-regulating site of HIV-1 selected by protease inhibitorsElena Knops, Léa Brakier-Gingras, Eugen Schülter, et al.
Intervirology|July 4, 2015
Proviral DNA as a Target for HIV-1 Resistance AnalysisNadine Lübke, Veronica Di Cristanziano, Saleta Sierra, et al.
Intervirology|January 31, 2012
Efficacy of antiretroviral therapy switch in HIV-infected patients: a 10-year analysis of the EuResist CohortMark Oette, Eugen Schülter, Michal Rosen-Zvi, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2010
Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolatesElena Knops, Martin Däumer, Sabine Awerkiew, et al.
Intervirology|January 31, 2012
Predicting response to antiretroviral treatment by machine learning: the EuResist projectMaurizio Zazzi, Francesca Incardona, Michal Rosen-Zvi, et al.
Medical Microbiology and Immunology|April 9, 2011
The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypesSaleta Sierra, Nadine Lübke, Hauke Walter, et al.
The Journal of Antimicrobial Chemotherapy|May 19, 2009
Evolution of raltegravir resistance during therapyNadine Sichtig, Saleta Sierra, Rolf Kaiser, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|February 9, 2010
The evolution of protease mutation 76V is associated with protease mutation 46I and gag mutation 431VElena Knops, Ina Kemper, Eugen Schülter, et al.
Medical Microbiology and Immunology|January 21, 2012
Endogenous or exogenous spreading of HIV-1 in Nordrhein-Westfalen, Germany, investigated by phylodynamic analysis of the RESINA Study cohortGlenn Lawyer, Eugen Schülter, Rolf Kaiser, et al.
Journal of the International AIDS Society|November 15, 2014
Time on drug analysis based on real life dataEugen Schülter, Rolf Kaiser, Maurizio Zazzi, et al.
Medical Microbiology and Immunology|December 28, 2011
Mutational patterns in the frameshift-regulating site of HIV-1 selected by protease inhibitorsElena Knops, Léa Brakier-Gingras, Eugen Schülter, et al.
Intervirology|July 4, 2015
Proviral DNA as a Target for HIV-1 Resistance AnalysisNadine Lübke, Veronica Di Cristanziano, Saleta Sierra, et al.
Intervirology|January 31, 2012
Efficacy of antiretroviral therapy switch in HIV-infected patients: a 10-year analysis of the EuResist CohortMark Oette, Eugen Schülter, Michal Rosen-Zvi, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 2010
Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolatesElena Knops, Martin Däumer, Sabine Awerkiew, et al.
Intervirology|January 31, 2012
Predicting response to antiretroviral treatment by machine learning: the EuResist projectMaurizio Zazzi, Francesca Incardona, Michal Rosen-Zvi, et al.
Medical Microbiology and Immunology|April 9, 2011
The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypesSaleta Sierra, Nadine Lübke, Hauke Walter, et al.
The Journal of Antimicrobial Chemotherapy|May 19, 2009
Evolution of raltegravir resistance during therapyNadine Sichtig, Saleta Sierra, Rolf Kaiser, et al.
Pageof 3